REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,635,923 | +1029.6% | 300,987 | +820.2% | 0.00% | – |
Q1 2023 | $321,866 | -27.5% | 32,710 | +8.4% | 0.00% | – |
Q4 2022 | $444,080 | -28.0% | 30,189 | -40.7% | 0.00% | – |
Q3 2022 | $617,000 | -8.2% | 50,900 | +6.0% | 0.00% | – |
Q2 2022 | $672,000 | +328.0% | 48,000 | +336.4% | 0.00% | – |
Q1 2022 | $157,000 | -87.3% | 11,000 | -81.2% | 0.00% | – |
Q4 2021 | $1,234,000 | +102.6% | 58,558 | +152.4% | 0.00% | – |
Q3 2021 | $609,000 | +9.1% | 23,200 | +29.6% | 0.00% | – |
Q2 2021 | $558,000 | +29.2% | 17,900 | +42.0% | 0.00% | – |
Q4 2020 | $432,000 | – | 12,606 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
Artal Group S.A. | 700,000 | $10,297 | 0.58% |
HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |